Talk Lung Cancer

Illustration of four people standing in a line

When it comes to lung cancer, every conversation is important. As our understanding and awareness of lung cancer grows, so does the opportunity to have candid conversations about it. These conversations are key to supporting you, those around you and the lung cancer community. No topic should ever be off limits or muddled in scientific jargon. Whether it’s clinical trials, biomarker testing or just everyday living…

It’s time to Talk Lung Cancer.

Let’s Talk:

Real-Life Stories

Every person who lives with lung cancer experiences the disease differently. By shining a light on the challenges they’ve faced and showing how support resources can help, these real stories can help you with your own journey.

View Admir, Anki and Annelie’s stories below:

We hear from Admir on his journey with lung cancer and his hopes for the future

Intensive care nurse, Anki, speaks about her incidental diagnosis with lung cancer

Annelie talks us through her diagnosis with lung cancer during her pregnancy

Let’s Talk:

Helpful Resources

The Talk Lung Cancer resources have been developed alongside members of the lung cancer patient community and healthcare professionals. Their aim is to take you from a place of doubt to a place of clarity on a number of important topics.

Illustration of two people sitting on a train
Front cover of a guide to living well with lung cancer
A guide for living well with
lung cancer
Front cover of a guide to biomarker testing for people with lung cancer
A guide to biomarker testing for people with lung cancer
Front cover of a question and answer guide for navigating biomarker testing with lung cancer
A question guide for navigating biomarker testing with your doctor
A guide to clinical trials for
people with lung cancer
Non-small cell lung cancer (NSCLC):
How it is managed and the important
role of biomarker testing
Illustration of two older people standing together

References

Myasthenia Gravis Foundation of America (MGFA). A Manual for the Healthcare Provider. Available at: https://myasthenia.org/Portals/0/Provider%20Manual_ibook%20version.pdf Last accessed: June 2024.
National Institute of Neurological Disorders and Stroke (NINDS). Myasthenia Gravis. Available at: https://www.ninds.nih.gov/health-information/disorders/myasthenia-gravis Last accessed: June 2024.
Dewilde S, et al. People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies. Adv Ther. Vol 40, 4377–4394 (2023). Available at: https://doi.org/10.1007/s12325-023-02604-z Last accessed: June 2024.
Mahic, et al. Healthcare resource use in myasthenia gravis: a US health claims analysis. Ther Adv Neurol Disorders (2023). Available at: https://doi.org/10.1177/17562864221150327 Last accessed: June 2024.
Daum P et al. Perioperative management of myasthenia gravis. BJA Education (2021) 21(11): 414e419
John Hopkins Medicine. Myasthenia Gravis. Available at: https://www.hopkinsmedicine.org/health/conditions-and-diseases/myasthenia-gravis Last accessed: June 2024.
Mishra A, et al. Myasthenia Gravis: A Systematic Review. Cureus (2023) 15(12): e50017. DOI 10.7759/cureus.50017.
Luo H, Xie S, Ma C, Zhang W, Tschöpe C, Fa X, Cheng J, Cao J. Correlation Between Thymus Radiology and Myasthenia Gravis in Clinical Practice. Front Neurol. 2019 Jan 15;9:1173. doi: 10.3389/fneur.2018.01173. PMID: 30697185; PMCID: PMC6340958.
Chen J, Tian D-C, Zhang C, et al. Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study. The Lancet Regional Health - Western Pacific. 2020;5(100063). https://doi.org/10.1016/j.lanwpc.2020.100063.
Lazaridis K, et al. Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics. Front Immunol. 2020 Feb 14;11:212. doi: 10.3389/fimmu.2020; 00212. Last accessed: June 2024.
Myasthenia Gravis Foundation of America (MGFA). Seronegative MG Resource Center. Available at: https://myasthenia.org/Newly-Diagnosed/Seronegative-MG-Resource-Center Last accessed: June 2024.
Jackson et al. Understanding the symptom burden and impact of myasthenia gravis from the patient’s perspective: A qualitative study. Neurology and Therapy. 2022;12:1; 107–128. Available at: https://doi.org/10.1007/s40120-022-00408-x.
Myasthenia Gravis Foundation of America (MGFA). Myasthenia Gravis Clinical Overview. Available at: https://myasthenia.org/Professionals/Clinical-Overview-of-MG#DIAGNOSTIC. Last accessed: June 2024
NHS. Myasthenia Gravis. Available at: https://www.nhs.uk/conditions/myasthenia-gravis/ Last accessed: June 2024.
NHS. Diagnosis Myasthenia Gravis. Available at: https://www.nhs.uk/conditions/myasthenia-gravis/diagnosis/ Last accessed: June 2024.